|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600117564 |
|
最近更新日期: Date of Last Refreshed on: |
2026-01-26 16:30:01 |
|
注册时间: Date of Registration: |
2026-01-26 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
周围神经选择性切断术及转移术联合康复训练对中枢性上肢痉挛瘫的临床疗效及机制探索 |
|
Public title: |
Clinical efficacy and mechanical exploration of peripheral nerve selective excision and transfer combined with rehabilitation training in central upper limb spastic paralysis |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
周围神经选择性切断术及转移术联合康复训练对中枢性上肢痉挛瘫的临床疗效及机制探索 |
|
Scientific title: |
Clinical efficacy and mechanical exploration of peripheral nerve selective excision and transfer combined with rehabilitation training in central upper limb spastic paralysis |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李军 |
研究负责人: |
李军 |
|
Applicant: |
Li Jun |
Study leader: |
Li Jun |
|
申请注册联系人电话: Applicant telephone: |
+86 13426489069 |
研究负责人电话: Study leader's telephone: |
+86 10 87569087 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
lijun2009crrc@163.com |
研究负责人电子邮件: Study leader's E-mail: |
lijun2009crrc@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市丰台区角门北路10号 |
研究负责人通讯地址: |
北京市丰台区角门北路10号 |
|
Applicant address: |
No. 10, Jiaomen North Road, Fengtai District, Beijing |
Study leader's address: |
No. 10, Jiaomen North Road, Fengtai District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京市中国康复研究中心北京博爱医院 |
||
|
Applicant's institution: |
China Rehabilitation Research Center,Beijing Bo'ai Hospital,Beijing |
||
|
研究负责人所在单位: |
北京博爱医院 |
||
|
Affiliation of the Leader: |
Beijing Bo'ai Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024-127-02 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国康复研究中心医学伦理委员会科研与医疗新技术新项目伦理组 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of China Rehabilitation Research Center |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-12-28 00:00:00 |
||
|
伦理委员会联系人: |
何照楠 |
||
|
Contact Name of the ethic committee: |
He Zhaonan |
||
|
伦理委员会联系地址: |
北京市丰台区角门北路10号 |
||
|
Contact Address of the ethic committee: |
No. 10, Jiaomen North Road, Fengtai District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 87020512 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
hznhzk@163.com |
|
研究实施负责(组长)单位: |
北京博爱医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Bo'ai Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市丰台区角门北路10号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.10, Jiaomen North Road, Fengtai District,Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选课题(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
optional project |
||||||||||||||||||||||
|
Target disease: |
Central nervous system injury diseases, such as stroke, cerebral palsy, traumatic brain injury, spastic paralysis of the upper limbs during the recovery period of spinal cord injury patients |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
观察周围神经选择性切断术+转移术或联合康复训练治疗中枢性上肢痉挛瘫患者痉挛的临床疗效及脑可塑性机制的探索。 |
||||||||||||||||||||||
|
Objectives of Study: |
Observation of the clinical efficacy and exploration of brain plasticity mechanisms in the treatment of spasticity in patients with central upper limb spastic paralysis by peripheral nerve selective dissection + transfer or combined rehabilitation training. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.12岁以上的脑卒中、脑瘫(偏瘫、三肢瘫、四肢瘫)、创伤性脑损伤、脑肿瘤、脑血管意外等中枢神经系统损伤伴肢体痉挛或中枢性痉挛瘫患者一年后出现上肢痉挛,且近3个月痉挛程度无变化; 2.痉挛状态经保守治疗(物理治疗、作业治疗、药物、肉毒毒素注射等)后无明显改善或复发; 3.改良Ashworth量表(MAS)≥2级,不伴上肢畸形。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients over 12 years old with stroke, cerebral palsy (hemiplegia, triple limb palsy, quadriple limb palsy), traumatic brain injury, cerebral tumor, cerebrovascular accident and other central nervous system injuries with limb spasticity or central spastic palsy develop spasticity of the upper limbs after one year and the degree of spasticity is unchanged in the last 3 months; 2. Spasticity state is not significantly improved or relapsed by conservative treatments (physical therapy, occupational therapy, medication, botulinum toxin injections, etc.); 3. Modified Ashworth Scale (MAS) >= grade 2 without upper limb deformity. |
||||||||||||||||||||||
|
排除标准: |
1.严重精神或认知障碍,不能配合康复训练; 2.严重原发性疾病或一般身体状况较差; 3.合并严重不可逆肌肉挛缩和骨畸形; 4.有手术或麻醉禁忌证者; 5.长期口服抗痉挛药物如巴氯芬、卡马西平等未停药者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. severe mental or cognitive impairment, unable to cooperate with the rehabilitation training; 2. serious primary disease or poor general physical condition; 3. combined with severe irreversible muscle contracture and bone deformity; 4. contraindications to surgery or anesthesia; 5. long term oral anti-spasticity drugs such as baclofen, carbamazepine, etc. have not been discontinued. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-12-01 00:00:00至 To 2026-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-12-26 00:00:00 至 To 2025-11-26 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用的是计算机随机化法:由1位未参与评估和治疗的研究成员使用SPASS27.0软件生成随机数字,随后填写相应的随机分配卡,并装入不透明的信封中密封,在签署知情同意书后,由患者家属打开信封,从而决定其分组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
In this study, 24 patients who met the inclusion criteria were randomly divided into the intervention group and the control group, 12 cases in each group. Intervention group: patients were treated with peripheral nerve balancing + rehabilitation training; control group: patients were treated with peripheral nerve balancing. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
单盲 |
|
Blinding: |
Single blind study |
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究公开发表后半年,邮件联系研究负责人合理获取。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Six months after the publication of the research, contact the research leader via email to obtain reasonable information. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
一、数据采集:1.纳入研究的患者在术前、术后1个月、术后3个月及术后6个月到门诊或住院部随访,由专业医师进行各项评估。2.对于每个评估指标,严格按照相应的标准和方法进行测量和记录,确保数据的准确性和可靠性。3.在数据采集过程中, 使用病历记录本记录患者的基本信息、治疗过程中的任何异常情况或并发症。二、数据管理:应用SPSS22.0版软件进行数据录入,建立数据库,计量资料采用均数±标准差(x±s)进行统计描述,若不符合正态分布,采用中位数或四分位间距进行统计学描述;满足正态分布采用t检验,不满足正态分布采用非参数检验,组内比较采用配对样本t检验,两组间比较采用两独立样本t检验。等级资料采用非参数秩和检验。组内采用配对Wilcoxon秩和检验,组间对比采用Mann-Whitney U秩和检验。以P≤0.05表示差异具有统计学意义。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
I. Data collection: 1. Patients included in the study were followed up in outpatient clinic or inpatient department before surgery, 1 month after surgery, 3 months after surgery and 6 months after surgery, and were assessed by professional physicians.2 For each assessment index, measurements and records were made in strict accordance with the corresponding standards and methods, to ensure the accuracy and reliability of the data.3. In the process of data collection, the patients' basic information, any abnormalities or complications in the treatment process, and any other information were recorded in the patient's medical records. Use the medical record book to record the patient's basic information, any abnormalities or complications in the treatment process. Data management: SPSS22.0 software was used for data entry and database establishment. Measurement data were statistically described by mean ± standard deviation (x ± s), and median or interquartile spacing was used for statistical descriptions if they did not meet the normal distribution; t-test was used to satisfy the normal distribution, and non-parametric test was used if they did not satisfy the normal distribution; paired samples t-test was used for comparison within the group, and two independent samples t-test was used for comparison between the two groups. Comparisons between groups were made using the paired samples t-test, and comparisons between two groups were made using the two independent samples t-test. Non-parametric rank-sum test was used for hierarchical data. The paired Wilcoxon rank sum test was used for within-group comparisons, and the Mann-Whitney U rank sum test was used for between-group comparisons. P≤0.05 indicated that the difference was statistically significant. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |